Integrated Disease Area Strategy Lead - GI

By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda’s Privacy Notice and Terms of Use. I further attest that all information I submit in my employment application is true to the best of my knowledge.

Job Description

As a member of Takeda Oncology, your work will contribute to our bold, inspiring vision: We aspire to cure cancer. Here, you'll build a career grounded in purpose and be empowered to deliver your best. As part of the Global Oncology Products, Pipeline and Strategy team, you will report to the Head of New Product Planning and Business Development Search & Evaluation, Global Oncology

How you will contribute:

• Serve as iDAS Business lead for Gastrointestinal (GI) and contribute to creating disease area strategies (DAS) to ensure Takeda maintains commercial leadership in these areas through pipeline planning and business development targeting. 

• Provide an early and objective view of the unmet needs, target profile, early product opportunity profile, market potential, competitive landscape and commercial risks associated with pipeline assets in early development phases in alignment with governance and enterprise needs.   Coordinate pre-commercialization activities for these pipeline assets prior to handing them off to commercial teams.

• Lead cross-functional global commercial teams to provide input into global product teams for pipeline assets; co-lead One Oncology iDAS teams to develop strategic and effective disease area strategies, including strategic updates, white space opportunity identification and other strategic issues as they arise

• Work with Business Development (BD), R&D, global commercial and regional commercial oncology colleagues to define and evolve the disease areas of interest for the Oncology Business Unit (OBU)

• Lead the assessment and quantification of business development opportunities for the OBU  and provide recommendations to the Oncology leadership team, ensuring decisions and plans are informed by the global market access landscape, competitive environment, unmet needs and customer/patient insights, including leading the commercial business subteam for BD opportunities for the creation of a business inputs into governance forums

Accountabilities:

• Represent the Oncology Business Unit (OBU) as GI lead on early pipeline Global Program Teams (GPTs) and contribute the global commercial perspective to clinical development decisions within the GPT (including Clinical, GMA, Project Management, and Regulatory) on  key factors such as indications, endpoints, populations and trial comparator to ensure through analysis and understanding of the necessary clinical and regulatory threshold to ensure successful commercialization ,market differentiation, and alignment with DASs.

• Co-lead GPT in identifying, developing and championing asset maximization strategies, and facilitate GPT decision-making through the communication of clear and unified global commercial strategy to optimize overall market value of each asset

• Develop early brand plans for GI assets with global cross-functional input (Patient value and Access, Medical Affairs, HEOR, Competitive Intelligence), including a global commercial assessment of the market and asset opportunity that is used to facilitate clinical development planning, brand strategy development, patient insights, value proposition, financial valuation, and tactical planning/budgeting

• Conduct market analyses to shape optimized target product profiles, early product opportunity profiles, product positioning, and target product claims

• Lead all regional pipeline communication and activities for GI assets

• Advise on commercial assessments of potential BD and M&A opportunities, acting as the lead f